EyeGene Inc (185490) — Financial Flexibility Index
EyeGene Inc (185490) has a Financial Flexibility Index of -0.23x as of March 2026. Free cash flow of ₩-3.12 Billion (operating CF ₩-3.13 Billion minus capex ₩6.53 Million) represents 0% of total liabilities (₩13.78 Billion). Check EyeGene Inc (185490) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
EyeGene Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for EyeGene Inc across 12 annual periods. See working capital to net assets of EyeGene Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for EyeGene Inc (2014–2025)
Year-by-year free cash flow to debt coverage for EyeGene Inc. For the full company profile including market capitalisation, see 185490 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.34x | ₩-4.76 Billion | ₩-5.98 Billion | ₩13.80 Billion | ▲ +28.1% |
| 2024 | -0.48x | ₩-7.18 Billion | ₩-12.17 Billion | ₩14.98 Billion | ▲ +64.1% |
| 2023 | -1.34x | ₩-18.40 Billion | ₩-20.07 Billion | ₩13.77 Billion | ▼ -2.5% |
| 2022 | -1.30x | ₩-17.80 Billion | ₩-18.57 Billion | ₩13.65 Billion | ▲ +24.4% |
| 2021 | -1.72x | ₩-27.63 Billion | ₩-30.00 Billion | ₩16.02 Billion | ▼ -604.1% |
| 2020 | -0.24x | ₩-7.72 Billion | ₩-9.75 Billion | ₩31.53 Billion | ▲ +5.5% |
| 2019 | -0.26x | ₩-7.33 Billion | ₩-8.32 Billion | ₩28.28 Billion | ▼ -9.9% |
| 2018 | -0.24x | ₩-7.24 Billion | ₩-7.48 Billion | ₩30.70 Billion | ▲ +76.3% |
| 2017 | -0.99x | ₩-6.49 Billion | ₩-6.76 Billion | ₩6.53 Billion | ▲ +47.6% |
| 2016 | -1.90x | ₩-4.49 Billion | ₩-5.99 Billion | ₩2.37 Billion | ▲ +31.8% |
| 2015 | -2.78x | ₩-4.35 Billion | ₩-4.48 Billion | ₩1.57 Billion | ▼ -130.2% |
| 2014 | -1.21x | ₩-2.04 Billion | ₩-2.39 Billion | ₩1.69 Billion | — |